282 related articles for article (PubMed ID: 24863391)
1. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY
Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391
[TBL] [Abstract][Full Text] [Related]
2. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
3. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
[TBL] [Abstract][Full Text] [Related]
4. DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer.
Song LJ; Liu Q; Meng XR; Li ShL; Wang LX; Fan QX; Xuan XY
Diagn Pathol; 2016 Feb; 11():19. PubMed ID: 26846339
[TBL] [Abstract][Full Text] [Related]
5. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance.
Qiu DM; Wang GL; Chen L; Xu YY; He S; Cao XL; Qin J; Zhou JM; Zhang YX; E Q
BMC Cancer; 2014 May; 14():327. PubMed ID: 24885292
[TBL] [Abstract][Full Text] [Related]
6. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation.
Li H; Wang S; Wang G; Zhang Z; Wu X; Zhang T; Fu B; Chen G
Dig Surg; 2014; 31(6):468-78. PubMed ID: 25632982
[TBL] [Abstract][Full Text] [Related]
7. Expression of claudin 10 protein in hepatocellular carcinoma: impact on survival.
Huang GW; Ding X; Chen SL; Zeng L
J Cancer Res Clin Oncol; 2011 Aug; 137(8):1213-8. PubMed ID: 21647678
[TBL] [Abstract][Full Text] [Related]
8. The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.
Yang SL; Liu LP; Jiang JX; Xiong ZF; He QJ; Wu C
Jpn J Clin Oncol; 2014 Feb; 44(2):159-67. PubMed ID: 24374892
[TBL] [Abstract][Full Text] [Related]
9. Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.
Liu W; Wang Y; Zhang C; Huang B; Bai J; Tian L
Int J Clin Exp Pathol; 2015; 8(4):4001-7. PubMed ID: 26097587
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma.
Pan LH; Yao M; Cai Y; Gu JJ; Yang XL; Wang L; Yao DF
World J Gastroenterol; 2016 Apr; 22(14):3829-36. PubMed ID: 27076768
[TBL] [Abstract][Full Text] [Related]
12. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
13. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
14. The expression of a tumor suppressor gene JDP2 and its prognostic value in hepatocellular carcinoma patients.
Chen YL; Chan SH; Lin PY; Chu PY
Hum Pathol; 2017 May; 63():212-216. PubMed ID: 28315425
[TBL] [Abstract][Full Text] [Related]
15. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
Zhang Y; Fan Y; Mei Z
Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
[TBL] [Abstract][Full Text] [Related]
16. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of FOXQ1 oncogene overexpression in human hepatocellular carcinoma.
Wang W; He S; Ji J; Huang J; Zhang S; Zhang Y
Pathol Res Pract; 2013 Jun; 209(6):353-8. PubMed ID: 23623360
[TBL] [Abstract][Full Text] [Related]
18. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of β1,6-N-acetylglucosaminyltransferase V expression in patients with hepatocellular carcinoma.
Liu H; Wu Q; Liu Y; Liu W; Zhang W; Pan D; Xu J
Jpn J Clin Oncol; 2015 Sep; 45(9):844-53. PubMed ID: 26056329
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.
Chua MS; Sun H; Cheung ST; Mason V; Higgins J; Ross DT; Fan ST; So S
Mod Pathol; 2007 Jan; 20(1):76-83. PubMed ID: 17170744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]